Cargando…
Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer
BACKGROUND: 5-Fluorouracil (5-FU) is the cornerstone of chemotherapeutic treatment for patients with colorectal cancer. The enzyme thymidine phosphorylase (TP) catalyzes the conversion of 5-FU to its active metabolite, 5-fluoro-2’-deoxyuridine. TP is expressed in tumour epithelial cells and stromal...
Autores principales: | Lindskog, Elinor Bexe, Derwinger, Kristoffer, Gustavsson, Bengt, Falk, Peter, Wettergren, Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058433/ https://www.ncbi.nlm.nih.gov/pubmed/24936150 http://dx.doi.org/10.1186/1472-6890-14-25 |
Ejemplares similares
-
Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer
por: Lindskog, Elinor B., et al.
Publicado: (2012) -
Impact of thymidine phosphorylase and CD163 expression on prognosis in stage II colorectal cancer
por: Kaidi, Donia, et al.
Publicado: (2022) -
A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer
por: Lindskog, Elinor Bexe, et al.
Publicado: (2014) -
Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival
por: Salimzadeh, Hamideh, et al.
Publicado: (2020) -
Increasing Dosage of Leucovorin Results in Pharmacokinetic and Gene Expression Differences When Administered as Two-Hour Infusion or Bolus Injection to Patients with Colon Cancer
por: Taflin, Helena, et al.
Publicado: (2022)